Table I.
Project | Funding Source | Period |
---|---|---|
Anaemia in SCD | The Wellcome Trust, UK | 2012–2016 |
H3ABioNET – Bioinformatics Award | NIH – University of Cape Town | 2012–2017 |
H3Africa Ethics in SCD | NIH – University of Cape Town | 2013–2017 |
mDOT | University of Pittsburgh | 2015–2017 |
Muhimbili Wellcome programme | The Wellcome Trust, UK | 2011–2016 |
Genomic research in SCD | The Wellcome Trust – Sanger | 2011–2015 |
Vascular Function in SCD | The Wellcome Trust – LSHTM | 2007–2014 |
Newborn screening for SCD | HDIF, DFID | 2015–2016 |
Sickle cell project | University of Oxford, UK | 2008–2010 |
Sickle cell study | The Wellcome Trust, UK | 2004–2007 |
DFID, Department for International Development; HDIF, Human Development Innovation Fund; LSHTM, London School of Hygiene and Tropical Medicine; mDOT, mobile-directly observed therapy for hydroxycarbamide use; NIH, National Institutes of Health; SCD, sickle cell disease.